Even after delivery into the tumor, TRAIL activity is evaded by TRAIL-resistant cancer cells, which express decoy receptors or inhibitors of the apoptotic pathway, such as cellular FADD-like interleukin-1β-converting enzyme (FLICE)-inhibitory protein (c-FLIP)15. Here, TNFSF10 is linked to neoplasm.